An Open-Label Safety Study of A-101 Solution

NCT02667288 · clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
147
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Aclaris Therapeutics, Inc.